← All trials
NCT04519125
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 30, 2020
- Primary completion
- Dec 31, 2020
- Completion date
- Apr 1, 2021
- First posted
- Aug 19, 2020
- Last posted
- Aug 19, 2020
- Enrollment
- 950
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Hospital Universitario San IgnacioLead sponsor
- Pontificia Universidad JaverianaCollaborator
- Hospital Universitario San IgnacioReponsible party - principal investigator
- Clínica ColsanitasCollaborator
- Fundación Universitaria Autónoma de Las AméricasCollaborator
- Hospital de la Samaritana, Sede Bogotá y Sede ZipaquiráCollaborator
- Universidad Nacional de ColombiaCollaborator
- Universidad Tecnológica de PereiraCollaborator
- Universidad Tecnológica de PereiraCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.